Toxys

company

About

Toxys is a Dutch biotech company.

  • 1 - 10

Details

Last Funding Type
Series A
Industries
Biotechnology,Health Care,Health Diagnostics
Founded date
Jan 1, 2014
Number Of Employee
1 - 10
Operating Status
Active

Toxys is a Dutch biotech company that provides innovative in vitro toxicity screening solutions to rapidly identify hazardous and potential carcinogenic properties of novel compounds during the early phases of product and drug development. We aim to bring information to our customers that is essential to make informed decisions on which compounds to progress in the drug/compound development pipeline, thereby contributing to the development of better medicines and products and to reduce animal testing.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
Toxys has raised a total of — in funding over 2 rounds. Their latest funding was raised on Feb 18, 2016 from a Series A round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Feb 18, 2016 Series A 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
Toxys is funded by 1 investors. Zeeuws Investerings Fonds are the most recent investors.
Investor Name Lead Investor Funding Round
Zeeuws Investerings Fonds Series A